The Global Market for Clinical Diagnostics Automation is Forecast to Exceed US$6.5 Billion by 2024

Rise in Annual Test Volumes & Growing Need to Improve Productivity Drive Adoption of Clinical Diagnostics Automation, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Clinical Diagnostics Automation market. The global market for Clinical Diagnostics Automation is forecast to exceed US$6.5 billion by 2024, driven by rise in annual test volumes and growing focus of laboratories to increase turnaround times, improve workflow efficiency and reduce operational costs.

.

Clinical diagnostic procedures have hitherto been manually-performed procedures, but automation in recent years has revolutionized the diagnosis industry. Automated testing is exponentially faster and provides results with very high accuracy, leading to lower treatment costs and higher survival rates. Automation is emerging as an essential requirement for labs, as they look to improve workflows to meet the demands arising from the increase in number of diagnostic tests performed. Growth would also be spurred by the immediate need of medical labs to automate lab processes, not only to increase capacity of clinical lab testing but also to enhance productivity. Shortage of trained technologists is a major factor driving the shift towards automation in clinical diagnostic laboratories. Increase in annual testing volumes due to aging global population, diagnostic and testing procedure innovations, and emerging challenges in the form of detection and identification of multidrug-resistant microorganisms are further driving demand for automation of clinical diagnostics in laboratories.

Overall, demand is on rise for flexible automation solutions, given the rising cost and complexity associated with the process of automation. A significant trend impacting the lab automation systems market is the reduction in sample load volumes to microliters and nanoliters. Some of the new automated systems integrate pre-analytical and analytical stages involved in sample processing and offer actionable results, while minimizing the potential for human errors. Trend towards automation, particularly modular automation among laboratories, is expected to fuel demand for standardized interfaces, thereby facilitating instruments manufactured by different vendors to be connected as well as operated together.

Modular systems of laboratory automation are emerging as ideal alternatives to total laboratory automation (TLA), due to small-scale implementation, flexibility, and small investment.

As stated by the new market research report on Clinical Diagnostics Automation, the United States represents the single largest market worldwide. Asia-Pacific is forecast to register fastest growth at a CAGR of 12.4% over the analysis period. Growth in the market is led by factors such as growing focus on improving healthcare services, emphasis on controlling costs of public hospitals, continuous rise in number of patients at primary healthcare centers, and rapid growth of private hospitals

Major players in the market include Abaxis Inc., Abbott Diagnostics Inc., Beckman Coulter Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Diagnostica Stago, Eppendorf AG, F Hoffmann-La Roche Ltd., HORIBA ABX SAS, Hudson Robotics Inc., Ortho Clinical Diagnostics Inc., PerkinElmer Inc., QIAGEN NV, Siemens Healthineers, Sysmex America Inc., Tecan Group Ltd., The ELITechGroup SAS, and Thermo Fisher Scientific Inc., among others.

The research report titled “Clinical Diagnostics Automation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, regulations, issues, challenges, mergers, acquisitions, and other strategic industry activities of major players worldwide. The report provides market estimates and projections in dollars for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Segments analyzed include Automated Analyzers, Total Lab Automation and Stand-alone Automation.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.